<div id="readability-page-1"><div><p>Hangzhou Tigermed Consulting Co., Ltd reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago. Revenue was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago.</p><p>Net income was CNY 887.89 million compared to CNY 405.14 million a year ago. Basic earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago. Diluted earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago.</p></div></div>

泰格医药

<p>杭州泰格医药咨询有限公司公布了截至 2025 年 12 月 31 日的全年财报。公司实现销售额 68.328 亿元人民币，较去年 66.0312 亿元人民币有所增长。净收入上升至 8.8789 亿元人民币，而去年为 4.0514 亿元人民币。持续经营业务的基本和摊薄每股收益均为 1.04 元人民币，较去年 0.47 元人民币有所增加</p>

杭州泰格医药咨询有限公司公布了截至2025年12月31日的全年财报结果